Franklin Biot.Discovery Fd.A USD/  LU0109394709  /

Fonds
NAV5/22/2019 Chg.-0.0200 Type of yield Investment Focus Investment company
30.2700USD -0.07% reinvestment Equity Worldwide Franklin Templeton 
 

Investment goal

The Fund aims to capital appreciation by investing principally in equity securities of biotechnology companies and discovery research firms mainly located in the US.
 

Master data

Type of yield: reinvestment
Funds Category: Equity
Region: Worldwide
Branch: Sector Biotechnology
Benchmark: NASDAQ Biotechnology Index
Business year start: 7/1
Last Distribution: -
Depository bank: J.P. Morgan Bank Luxembourg S.A.
Fund domicile: Luxembourg
Distribution permission: Austria, Germany, Switzerland, Netherlands, France, United Kingdom, Belgium, Denmark, Greece, Hong Kong, Ireland, Italy, Norway, Portugal, Singapore, Spain, Luxembourg, Sweden, Finland, Poland, Hungary, Czech Republic, Slovakia (Slovak Republic)
Fund manager: E. McCulloch, S. Kornfeld, W. Lam
Fund volume: 1.84 bill.  USD
Launch date: 4/3/2000
Investment focus: Mid Cap

Conditions

Issue surcharge: 5.75%
Max. Administration Fee: -
Minimum investment: 2,500.00 USD
Deposit fees: 0.14%
Redemption charge: 0.00%
Ongoing charges (12/31/2018): 1.82%
Key Investor Information: Download (Print version)
 

Investment company

Funds company: Franklin Templeton
Address: Universitätsring 10, 1010, Wien
Country: Austria
Internet: www.franklintempleton.at
 

Assets

Stocks
 
91.85%
Cash and Other Assets
 
7.33%
Others
 
0.82%

Countries

United States of America
 
79.21%
United Kingdom
 
3.67%
Netherlands
 
2.46%
Denmark
 
2.43%
Ireland
 
2.09%
Canada
 
0.69%
Switzerland
 
0.56%
Germany
 
0.53%
Israel
 
0.22%
Others
 
8.14%

Branches

Pharma/Biotechnology
 
58.01%
Pharma, production
 
30.52%
Cash / other assets
 
7.33%
Healthcare services
 
3.32%
Others
 
0.82%